USH1 protein network component sans ; Homo sapiens

211 Article(s)
Pub. Date
#Total Relationship(s)
1 1683624 [Chemotherapies of negative schizophrenia]. Encephale 1991 Jul-Aug 1
2 7856324 [Effect of clozapine on biogenic amines within the scope of drug treatment of schizophrenic psychoses in adolescence]. Z Kinder Jugendpsychiatr 1994 Dec 1
3 7894879 Treatment of negative symptoms in schizophrenia with amisulpride. Br J Psychiatry 1995 Jan 1
4 7902766 Ritanserin, a selective 5-HT2/1C antagonist, and negative symptoms in schizophrenia. A placebo-controlled double-blind trial. Br J Psychiatry 1993 Oct 1
5 8149734 Clozapine's effect on negative symptoms in treatment-refractory schizophrenics. Compr Psychiatry 1994 Jan-Feb 1
6 8545499 Lateralized abnormality of high-energy phosphate and bilateral reduction of phosphomonoester measured by phosphorus-31 magnetic resonance spectroscopy of the frontal lobes in schizophrenia. Psychiatry Res 1995 Sep 29 1
7 8552110 Ball experiments in 32 acute akinetic catatonic patients: deficits of internal initiation and generation of movements. Mov Disord 1995 Sep 1
8 8775759 Haloperidol plasma 'threshold' levels for relapse prevention in schizophrenia: a study with haloperidol decanoate. Eur Neuropsychopharmacol 1995 1
9 8926856 [Bromperidol decanoate in the residual phase of schizophrenia]. Minerva Psichiatr 1996 Mar 1
10 8927680 A comparison of an atypical and typical antipsychotic, zotepine versus haloperidol in patients with acute exacerbation of schizophrenia: a parallel-group double-blind trial. Psychopharmacol Bull 1996 1
11 8942463 D-cycloserine added to clozapine for patients with schizophrenia. Am J Psychiatry 1996 Dec 2
12 9031507 Small-angle neutron scattering instrument of institute for solid state physics, the University of Tokyo (SANS-U) and its application to biology. Basic Life Sci 1996 1
13 9090332 Negative symptoms: a path analytic approach to a double-blind, placebo- and haloperidol-controlled clinical trial with olanzapine. Am J Psychiatry 1997 Apr 2
14 9131723 Improvement of cognitive function in schizophrenic patients receiving clozapine or zotepine: results from a double-blind study. Pharmacopsychiatry 1997 Mar 2
15 9218164 Clinical update on amisulpride in deficit schizophrenia. Int Clin Psychopharmacol 1997 May 1
16 9270900 Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group. Biol Psychiatry 1997 Aug 15 1
17 9377587 Famotidine adjunctive pharmacotherapy for schizophrenia: preliminary data. Clin Neuropharmacol 1993 Dec 1
18 9630000 A comparison of bd and tid dose regimens of quetiapine (Seroquel) in the treatment of schizophrenia. Psychopharmacology (Berl) 1998 May 1
19 9892252 A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia. Arch Gen Psychiatry 1999 Jan 1
20 10092363 Small-Angle Scattering and Electron Microscopy Investigation of Nanotubules Made from a Perfluoroalkylated Glucophospholipid. J Colloid Interface Sci 1999 Apr 15 1
21 10591990 Dimensions of psychopathology in paranoid schizophrenia. Eur Arch Psychiatry Clin Neurosci 1999 1
22 10773770 Objective and subjective extrapyramidal side effects in schizophrenia: their relationships with negative and depressive symptoms. Psychopathology 2000 May-Jun 1
23 11271525 The self-assembly of a lipophilic guanosine nucleoside into polymeric columnar aggregates: the nucleoside strucutre contains sufficient information to drive the process towards a strikingly regular polymer. Chemistry 2001 Jan 19 1
24 12693427 Amisulpride: is there a treatment for negative symptoms in schizophrenia patients? Schizophr Bull 2002 1
25 12794651 [Distinguishing depressive from nondepressive patients in schizophrenia in terms of symptomatology]. Turk Psikiyatri Derg 2002 Autumn 1
26 12909392 [Effects of a subanaesthetic dose of ketamine on emotional and behavioral state in healthy subjects]. Neurophysiol Clin 2003 Jun 1
27 14628974 Comparison of risperidone and olanzapine in the control of negative symptoms of chronic schizophrenia and related psychotic disorders in patients aged 50 to 65 years. J Clin Psychiatry 2003 Sep 3
28 15011061 Persistence length for a model semirigid polyelectrolyte as seen by small angle neutron scattering: a relevant variation of the lower bound with ionic strength. Eur Phys J E Soft Matter 2003 Feb 1
29 15076014 The effect of mirtazapine augmentation of clozapine in the treatment of negative symptoms of schizophrenia: a double-blind, placebo-controlled study. Int Clin Psychopharmacol 2004 Mar 2
30 15338437 Structure of hydrophobically and hydrogen-bonded complexes between amphiphilic copolymer and polyacid in water. Eur Phys J E Soft Matter 2004 Jul 2
31 15625211 Clozapine augmented with risperidone in the treatment of schizophrenia: a randomized, double-blind, placebo-controlled trial. Am J Psychiatry 2005 Jan 3
32 15796511 Highly extended conformation of polyelectrolytes incorporated into hybrid threadlike micelles studied by small angle neutron scattering. J Am Chem Soc 2005 Apr 6 3
33 15807604 SANS study of the interactions among DNA, a cationic surfactant, and polystyrene latex particles. Langmuir 2005 Apr 12 1
34 16008378 Mixed micelles formed by SDS and a bolaamphiphile with carbohydrate headgroups. Langmuir 2005 Jul 19 1
35 16008385 Giant micellar worms under shear: a rheological study using SANS. Langmuir 2005 Jul 19 1
36 16231078 Quantitative analysis of lyotropic lamellar phases SANS patterns in powder oriented samples. Eur Phys J E Soft Matter 2005 Nov 1
37 16231604 Structure and assembly of PEO-PPO-PEO co-polymers in mammalian cell-culture media. J Biomater Sci Polym Ed 2005 3
38 16275807 Sarcosine or D-serine add-on treatment for acute exacerbation of schizophrenia: a randomized, double-blind, placebo-controlled study. Arch Gen Psychiatry 2005 Nov 5
39 16513871 Negative signs and symptoms secondary to antipsychotics: a double-blind, randomized trial of a single dose of placebo, haloperidol, and risperidone in healthy volunteers. Am J Psychiatry 2006 Mar 3
40 16553461 Loose complexation of weakly charged microemulsion droplets and a polyelectrolyte. J Phys Chem B 2006 Mar 30 2
41 16702888 A randomized, 1-year follow-up study of olanzapine and risperidone in the treatment of negative symptoms in outpatients with schizophrenia. J Clin Psychopharmacol 2006 Jun 2
42 16783811 Quetiapine versus olanzapine for the treatment of negative symptoms in patients with schizophrenia. Hum Psychopharmacol 2006 Jun 4
43 16800661 Different properties of H2O- and D2O-containing phospholipid-based reverse micelles near a critical temperature. Langmuir 2006 Jul 4 5
44 16820255 Improvement in social functioning in outpatients with schizophrenia with prominent negative symptoms treated with olanzapine or risperidone in a 1 year randomized, open-label trial. Prog Neuropsychopharmacol Biol Psychiatry 2006 Dec 30 1
45 16851102 Scattering curves of ordered mesoscopic materials. J Phys Chem B 2005 Feb 3 1
46 16852582 Evolution of self-assembled silica-tetrapropylammonium nanoparticles at elevated temperatures. J Phys Chem B 2005 Jul 7 1
47 16952236 Phase behavior, topology, and growth of neutral catanionic reverse micelles. Langmuir 2006 Sep 12 1
48 17025363 Synthesis, characterization, and gene transfer application of poly(ethylene glycol-b-ethylenimine) with high molar mass polyamine block. Biomacromolecules 2006 Oct 1
49 17065975 Efficacy of olanzapine and risperidone in schizophrenia: a randomized double-blind crossover design. Psychopharmacol Bull 2006 1
50 17149903 Charge stoichiometry inside polyelectrolyte-protein complexes: a direct SANS measurement for the PSSNa-lysozyme system. J Phys Chem B 2006 Dec 14 1